Dithiazide

Quick links to important sections

Dithiazide

Selected form

Method of action: Diuretic

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dithiazide

Property Description
Active ingredient Hydrochlorothiazide (HCTZ)
Form Tablet, Capsule
Pharmacological class Thiazide diuretic, Antihypertensive
Common use Management of excess fluid and blood pressure
Origin Synthetic, Sulfonamide derivative

Dithiazide is a prescription-only medicinal product, classified as a thiazide diuretic and used generally as an antihypertensive agent. Its single active ingredient is Hydrochlorothiazide (HCTZ), a synthetic compound widely recognized as an essential medicine compound. This compound is chemically characterized as a sulfonamide derivative.

As a single-ingredient product, Dithiazide belongs to a distinct class of small molecule drugs that modulate salt and water balance in the body. It is supplied for oral administration, most commonly formulated into a stable tablet or capsule using pharmaceutical excipients. The thiazide class of diuretics is clinically recognized as a highly effective first-line option for treating hypertension. This recognition underscores the drug's established role in supporting healthy blood pressure levels.


Dithiazide's Function: High-Level Purpose

The general purpose of Dithiazide is to manage excess fluid volume in the body by promoting diuresis, or increased urine output. This action directly contributes to the core benefit of reducing high blood pressure and alleviating peripheral fluid accumulation.

Hydrochlorothiazide achieves this by enhancing the elimination of sodium and chloride salts via the kidneys. This type of medication works by causing the kidneys to get rid of unnecessary water and salt. This primary physiological action is useful for individuals needing long-term support for their fluid retention, such as managing mild to moderate oedema linked to conditions like congestive heart failure. The compound is fundamental to its role as an antihypertensive agent by easing the burden on the cardiovascular system.

Regulatory References

  1. essential medicine (WHO)

What side effects are possible with Dithiazide?

Safety and Side Effects

Dithiazide, which contains the active ingredient hydrochlorothiazide, is associated with a range of possible side effects, spanning common occurrences to rare but serious adverse reactions.

Common Adverse Reactions

Side effects often observed include electrolyte imbalances (e.g., low potassium or sodium levels), which can manifest as dry mouth, thirst, muscle pains or cramps, weakness, and fast heart rate. Other common effects involve the nervous system (dizziness, headache) and gastrointestinal tract (nausea, vomiting, stomach cramps, or appetite loss).

Serious and Clinically Significant Risks

The following are serious safety concerns documented in regulatory information:

  • Ocular Events: The medication is linked to an idiosyncratic reaction leading to acute transient myopia, choroidal effusion, and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or eye pain, typically within hours to weeks of initiation, and require immediate discontinuation and medical intervention to prevent permanent vision loss.
  • Skin Cancer Risk: An increased risk of non-melanoma skin cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) has been identified with increasing cumulative doses over time. Patients should be advised to limit sun exposure and undergo regular skin examinations.
  • Acute Respiratory Distress Syndrome (ARDS): This is a very rare, severe pulmonary adverse event that may develop rapidly after intake.

Safety Restrictions and Population Considerations

Dithiazide is contraindicated in patients with anuria (inability to pass urine) and in those with known hypersensitivity to the drug or other sulfonamide-derived medicines. Caution is advised in patients with severe hepatic or renal impairment, as the drug may precipitate complications like hepatic coma or azotemia. The risk of electrolyte disturbances is also noted to be dose-dependent.

Overdose and Emergency Response

Dithiazide Overdose and when to seek help

An overdose of Dithiazide is primarily defined by the resulting profound depletion of body fluid and key electrolytes, a condition that mandates immediate attention. Officially documented manifestations stem from excessive diuresis, leading to signs like hypotension (severely low blood pressure), tachycardia (rapid heart rate), weakness, and confusion. Laboratory findings consistently show critical imbalances, notably hypokalemia (low serum potassium) and hyponatremia (low serum sodium).

Regulatory bodies document that severe, life-threatening complications may arise from these imbalances, including the risk of ventricular arrhythmias and the development of life-threatening dilutional hyponatremia. Specific populations, such as those with severe cirrhosis, face increased risk. Immediate medical help must be sought right away for any suspected overdose or for any severe symptoms, particularly excessive hypotension.

As no specific antidote is known, the management strategy is strictly symptomatic and supportive. This involves correcting the volume depletion and electrolyte imbalances, often requiring procedures like intravenous infusion of normal saline. Regulatory labeling emphasizes the necessity of continuous monitoring, specifically the periodic determination of serum electrolytes, throughout the management process.

Therapeutic Uses of Dithiazide

What Dithiazide Treats: Main Uses and Benefits

Dithiazide is relevant for easing symptoms related to systemic imbalance and cardiovascular risk by managing fluid volume and addressing elevated arterial pressure. The primary therapeutic purpose is to assist in the management of high blood pressure. This supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability. Additionally, the medication is commonly used to help with high blood pressure, fluid accumulation (edema) stemming from chronic heart, liver, or kidney conditions, and specific urinary mineral imbalances like hypercalciuria.

The medication may be applied in addressing symptom clusters related to fluid retention that create noticeable physiological strain. It is generally applied in settings where symptoms become more noticeable, offering supportive relief.

Quick Fact: Relief for Peripheral Swelling Dithiazide supports patients during periods of heightened discomfort by easing the physical burden of swelling in the legs and ankles, which contributes to improved day-to-day comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information Overview

Eligibility and Restrictions for Use

Dithiazide is a prescription medicine and its use is strictly governed by regulatory guidelines that define which populations are eligible to use it and which are not.

Populations That Must Not Use Dithiazide (Contraindications)

Official labeling contraindicates the use of Dithiazide in the following populations:

  • Anuria: Patients who have an inability to produce urine must not use this medicine.
  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to the drug's components or to other sulfonamide-derived medicines (sulfonamide-derived drugs) are prohibited from using it.

Use with Caution and Restrictions

Certain physiological states and medical conditions require special consideration and may restrict or limit the use of Dithiazide:

  • Severe Organ Impairment: Use requires caution in patients with severe renal disease (as it may worsen kidney function) and in patients with impaired hepatic function or progressive liver disease (as minor fluid changes could precipitate hepatic coma).
  • Pregnancy: The routine use of diuretics in otherwise healthy pregnant women is officially considered inappropriate or not indicated.
  • Lactation: The drug is excreted in breast milk, and use is generally not recommended due to the potential for adverse effects in the nursing infant.
  • Other Conditions: Caution is advised for patients with a history of Systemic Lupus Erythematosus (SLE), as the drug may worsen or reactivate the condition, and those with a history of acute respiratory distress syndrome (ARDS) following hydrochlorothiazide intake.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with Dithiazide (Hydrochlorothiazide) into specific functional categories. Contraindicated combinations strictly include use in patients with Anuria or Severe Hepatic or Renal Impairment. Use is also prohibited in individuals with known hypersensitivity to any sulfonamide-derived drug.

Documented Pharmacodynamic Interactions often involve additive effects. Co-administration with other antihypertensive drugs or central nervous system depressants, such as alcohol or narcotics, may potentiate blood pressure lowering or orthostatic hypotension. Combining the drug with Corticosteroids or ACTH may intensify hypokalemia. Conversely, NSAIDs may oppose this effect by reducing the drug’s diuretic and antihypertensive efficacy.

Pharmacokinetic Interference is officially documented for several substances. Lithium clearance is reduced by Dithiazide, which significantly increases the risk of lithium toxicity and requires caution. Bile acid sequestrants such as Cholestyramine and Colestipol resins reduce the drug's absorption. To address this exposure change, official labeling mandates a timing separation: Dithiazide must be administered at least one hour before or four to six hours after the resin. Separating doses from Antacids and certain mineral supplements is also required. Furthermore, an interaction exists where the drug may impair glucose tolerance, which is an important consideration in the diabetic population.

Mechanism of Action

Molecular Blockade of Salt Reabsorption

Dithiazide's action is fundamentally governed by its specific impact on two interconnected biological systems: renal fluid regulation and systemic vascular tone.

The core mechanism involves the direct inhibition of the Sodium Chloride Co-Transporter (NCC), a specific ion channel located in the kidney's Distal Convoluted Tubule. By blocking this protein, the drug prevents the reabsorption of sodium (Na^+) and chloride (Cl^-) back into the bloodstream. This initial molecular action initiates the physiological cascade associated with the drug's effect by modulating renal electrolyte transport.

Dual Action on Fluid Volume and Vascular Resistance

The reduced reabsorption of salt creates an osmotic gradient, leading to natriuresis (salt excretion) and diuresis (water excretion), which results in an acute reduction in Extracellular Fluid Volume. This initial volume loss is then followed by a separate, long-term mechanism involving the sustained reduction of Peripheral Vascular Resistance (vasodilation). This dual mechanistic action—fluid regulation and vascular tone adjustment—contributes to the modulation of pressure within the systemic circulation.

Dosage and Administration Information

How to Use Dithiazide: Official Administration Guidelines

Hydrochlorothiazide, the active ingredient in Dithiazide, is typically used according to clinical guidelines. The medicine is consistently prescribed for oral administration and is available in forms including the Tablet, Capsule (e.g., 12.5 mg, 25 mg, and 50 mg strengths), and a Powder for Oral Suspension.


Standard Administration Scope

Field Instruction
Route of administration Oral
Dosing schedule Hypertension: Initial dose is often 25 mg once daily; maintenance ranges up to 50 mg daily. Edema: Usual range is 25 mg to 100 mg daily.
Timing in relation to meals May be administered with or without food.
Preparation requirements The Powder for Oral Suspension requires reconstitution with water and must be shaken well prior to use.
Special procedural conditions Administration is generally advised early in the day (morning) to avoid nighttime sleep disturbance due to increased urination.

Dosing Frequency and Constraints

The medicine is typically taken once daily, though the total daily dose may be given in two divided doses. For managing edema, an intermittent schedule is often employed, such as administration on alternate days or for three to five days each week. Dosage must be carefully determined, as the medicine is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 mL/min).

Recent Clinical Evidence

Research Evidence Overview for Dithiazide


Evidence for Use in High Blood Pressure (Hypertension)

Research has extensively explored Dithiazide, often in combination with other agents, within the context of conditions characterized by systemic or functional imbalance, such as high blood pressure. These studies, which include large randomized controlled trials (RCTs), monitored outcomes related to blood pressure readings in adult populations. Findings describe patterns observed in these studies, where changes in both systolic and diastolic blood pressure levels were observed in populations receiving Dithiazide over defined time intervals. This research highlights what has been observed so far in studies exploring this condition.

What remains uncertain is the extent of comparative evidence that examined Dithiazide against certain other types of medication, as findings were observed to be mixed across different studies and comparison groups. The results apply only to the populations studied, which means research does not determine whether an individual will respond similarly.


Evidence for Use in Fluid Build-up (Oedema)

Dithiazide was studied for its evaluation in studies focused on excess fluid in the body, a condition sometimes called oedema. This research explored its application in studies examining patient-reported experiences and outcomes related to physical discomfort caused by swelling. The study populations evaluated included individuals with oedema and certain pre-existing heart, liver, or kidney conditions. Research describes patterns observed in the studies regarding the evolution of fluid retention and swelling, sometimes in conditions presenting with cycles of stability and flare-ups.

Evidence quality varies across studies, and some trials assessing short-term symptom patterns report how symptoms evolved in the observed populations over shorter follow-up durations. Data for certain groups remain insufficient, particularly for people with less common causes of fluid build-up or those with significant differences in organ function.


Evidence for Use in Cardiovascular Outcomes

Long-term, large-scale studies and systematic reviews have explored Dithiazide in research focused on cardiovascular outcomes, particularly in adult populations with pre-existing high blood pressure. These studies monitored the occurrence of major cardiovascular events, such as heart attack and stroke. Research highlights patterns of incidence measured during the study period for these outcomes. The data show patterns related to cardiovascular events and contribute to the broader evidence landscape for therapies studied in this area.


What is Still Uncertain About Dithiazide

Research provides context, but uncertainty remains across several areas. Comparative evidence is lacking regarding the findings of Dithiazide versus other available agents for every single outcome. Furthermore, long-term effects are not fully established for all populations, and the follow-up durations were limited in many studies focused on specific subgroups. The research provides insight into short-term changes, but further studies are ongoing to address the complexity of conditions characterized by fluctuating or episodic manifestations across a lifetime. This evidence highlights what is known—and what is still uncertain—about Dithiazide.

Key Studies & References

  1. NICE Guideline: Hypertension in adults: diagnosis and management (NG136) - Evidence for Diuretic Use

Frequently Asked Questions (FAQ)

Common questions about Dithiazide (FAQ)


Q: What kind of foods or drinks interact with Dithiazide?

Official documents note that the use of alcohol may potentiate blood pressure-lowering effects. High-sodium foods are generally advised against as they may counteract the medication's intended effect.

Official labeling states a requirement for separation from certain resins and mineral supplements due to potential absorption interference.


Q: Does Dithiazide have an official safety classification during pregnancy?

Official patient information states that the drug is known to cross the placental barrier. Routine use in otherwise healthy pregnant individuals is officially considered inappropriate due to the potential for fetal hazards documented in official labeling, such as jaundice or thrombocytopenia (low platelet count).


Q: Do studies suggest Dithiazide is effective for its stated purpose?

Clinical studies have examined outcomes and reported that lowering high blood pressure with this medication class has been associated with a reduction in the risk of serious cardiovascular events, such as heart attack and stroke.

The antihypertensive effect typically becomes visible within about one week, with maximal observed effects seen around four weeks of use.


Q: Can Dithiazide interact with common over-the-counter pain relievers?

Official drug labels state that Non-steroidal Anti-inflammatory Drugs (NSAIDs) may antagonize the diuretic and antihypertensive effects of Dithiazide. This combination may also be linked to an increased risk of certain kidney problems.


Q: Is it true that Dithiazide can affect potassium levels?

Yes, official documents state that the medication can lead to low potassium levels, known as hypokalemia, due to increased loss through urine.

Official labeling advises observation for signs of this electrolyte imbalance, such as muscle pain or weakness.


Q: Can Dithiazide cause skin reactions or increased sun sensitivity?

Official information indicates an association between the cumulative use of this drug over time and an increased risk of non-melanoma skin cancer.

Due to this risk, official patient information often includes recommendations to limit sun exposure and undergo regular skin examinations.


Q: Why do official documents mention electrolyte monitoring with Dithiazide use?

Official product information advises the periodic determination of serum electrolytes (like sodium and potassium levels) to detect possible imbalances.

The rationale is to detect possible fluid and electrolyte imbalances that may occur, such as low sodium (hyponatremia) or low potassium (hypokalemia).


Q: What happens if Dithiazide is taken when a person is already dizzy or lightheaded?

Dizziness and lightheadedness are listed as potential adverse reactions to the medication. These symptoms may be aggravated by other factors like alcohol or hypotension.

Patient counseling often highlights the importance of using caution when standing up to minimize these effects.


Q: Is the onset of action of Dithiazide immediate or gradual?

The fluid-regulating effect (diuresis, or increased urine production) typically begins within two hours of taking the dose and lasts approximately 6 to 12 hours.

The full antihypertensive effect observed in studies may take up to four weeks to fully manifest.


Q: Can Dithiazide affect blood sugar levels, according to official information?

Yes, the official product information indicates that the medication may impair glucose tolerance (the body's ability to use sugar).

This can potentially result in elevated blood sugar levels (hyperglycemia), which is an important consideration for individuals with diabetes.


Q: Why is Dithiazide sometimes prescribed for conditions other than high blood pressure?

In addition to high blood pressure and fluid build-up (edema), the drug is also indicated as adjunctive therapy for fluid accumulation associated with other conditions.

These include edema linked to hepatic cirrhosis and certain renal dysfunctions, or to treat diabetes insipidus.


Q: Is Dithiazide intended for short-term or long-term use?

Regulatory documents describe Dithiazide as indicated for the long-term management of chronic conditions such as high blood pressure.

For fluid build-up, use may follow an intermittent schedule or be short-term for acute conditions.


Q: Does Dithiazide cause fatigue or tiredness as a side effect?

Official labeling reports that adverse reactions such as fatigue and drowsiness (somnolence) are possible. These symptoms may be related to changes in fluid or electrolyte balance caused by the drug's mechanism of action.


Q: Can Dithiazide affect sleep patterns?

Dosing instructions advise taking the medication early in the day to prevent the increased nighttime urination that could disturb sleep.

Restlessness and drowsiness are also noted in official adverse reaction lists as potential effects that could influence sleep patterns.


Q: Are there specific vitamins or supplements that should not be taken with Dithiazide?

Regulatory labels require separating the administration of Dithiazide from certain mineral supplements and antacids due to potential interference with the drug's absorption.

Specific interactions with other vitamins are not comprehensively listed.


Q: Is it typical for Dithiazide to be combined with other medicines?

Yes, official indications state that the drug may be used as a sole therapeutic agent or to enhance the effectiveness of other medications used to treat more severe high blood pressure.


Q: Are there any age restrictions for using Dithiazide?

The drug has established dosages for pediatric patients, including children less than 2 years old and those up to age 11, for certain indications.

Older adults (age 65 and over) are advised to use caution as they may be at a greater risk for fluid and electrolyte imbalances.


Q: Does Dithiazide require any special monitoring or tests while taking it?

Yes, official labeling recommends the periodic determination of serum electrolytes (blood levels of salt and potassium) and observation for clinical signs of fluid imbalance.

Monitoring of renal (kidney) function may also be necessary for some susceptible patients.


Q: Is Dithiazide a generic drug, or does it have different brand names?

Dithiazide's active ingredient is Hydrochlorothiazide (HCTZ), which is a common generic compound.

HCTZ is recognized as a generic compound and is listed in official documents as being sold under various brand names, often in combination products.


Q: What happens if a dose of Dithiazide is missed?

Official patient information outlines instructions for handling a missed dose, generally stating that it should be taken as soon as it is remembered, unless it is close to the next scheduled dose time.

Doubling the dose is advised against in patient information.


Q: Is Dithiazide known to cause dehydration, and what are the signs?

While the term dehydration is not always explicitly listed, the drug's strong diuretic effect (increased urination) can lead to volume loss.

Signs of a possible fluid and electrolyte imbalance may include dry mouth, increased thirst, weakness, or a fast heart rate.


Q: What are the regulatory warnings or boxed warnings associated with Dithiazide?

The FDA label for Dithiazide as a single agent does not currently carry an official Boxed Warning. However, the Warnings and Precautions section does address serious risks, including the potential for acute eye conditions (glaucoma) and the increased risk of non-melanoma skin cancer.


Q: Is Dithiazide safe to use when driving or operating machinery?

Patient counseling highlights the potential for side effects such as dizziness or drowsiness. Official patient information notes that using caution when driving or operating machinery is necessary until an individual is certain how the medication affects them.


Q: Why is it important to know about all medications when starting Dithiazide?

It is important because the medication has documented interactions that can alter the effect of either Dithiazide or the other drug being taken.

These interactions include those that potentiate the blood pressure-lowering effect and those that interfere with absorption.


Q: What kind of research has been done on the long-term effects of Dithiazide?

Research on Dithiazide and its drug class includes long-term, large-scale studies. These studies have monitored important outcomes related to sustained blood pressure readings and the overall occurrence of major cardiovascular events, such as heart attack and stroke.


Q: Does Dithiazide interact with caffeine or high-sodium foods?

High-sodium foods are generally advised against because excessive sodium intake may reduce the intended blood pressure-lowering effect of the medication.

Caffeine is not typically listed as a direct drug-drug interaction in the primary labels.


Q: What common blood tests might Dithiazide affect?

The drug may affect blood tests by potentially altering levels of key substances. Specifically, it can influence blood levels of sodium and potassium, as well as uric acid (potentially causing hyperuricemia) and glucose (potentially causing hyperglycemia).


Q: Is Dithiazide described as a first-line treatment for its main indication?

Official guidelines recognize the drug class (thiazides) as a first-line option for treating high blood pressure.

It is often used alone or in combination with other antihypertensive agents to manage the condition.


Q: What is the typical timeframe for a doctor to review Dithiazide's effectiveness?

The antihypertensive effect is typically observed to maximize around four weeks of therapy. This timeframe is often used as a consideration for review of potential dose adjustments.


Q: What are the potential signs of an interaction when taking Dithiazide?

Signs of a potential interaction may include a significant drop in blood pressure, which could manifest as dizziness or fainting.

An interaction that intensifies low potassium (hypokalemia) may show up as muscle cramps or excessive dry mouth.


Q: Can Dithiazide be taken by individuals who follow a specific diet, like low-salt?

Official patient information often describes the use of a low-sodium diet alongside this medication to help support its blood pressure-lowering effect.

However, official guidance is against overly restrictive salt intake that could lead to overly low blood pressure.


Q: What are the key safety considerations for older adults using Dithiazide?

Official documents note that older adults (age 65 and over) may be at a greater risk for some adverse effects.

Specific caution is advised regarding the potential for fluid and electrolyte imbalances in this population, as older adults may process drugs more slowly.

How should Dithiazide be stored and disposed of?

How to Store and Dispose of Dithiazide

Official regulatory guidelines define precise storage and disposal requirements to maintain the integrity of Dithiazide (Hydrochlorothiazide).

Storage Conditions

Dithiazide tablets must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The medicine must be kept away from heat, moisture, and direct light in a well-closed container. It is strictly required not to freeze the medication.

Handling and Safety

For child safety, the medication must be stored out of the reach of children.

Disposal Instructions

Do not keep medicine that is outdated or no longer needed. Users must ask a healthcare professional how any unused medicine should be disposed of to ensure proper pharmaceutical waste handling and adherence to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dithiazide found in:

A-Z Index: